New @Nature study: >50% of lung cancer metastases are seeded by other metastases, not the primary tumor. This "seeding from seeding" reveals a complex evolutionary cascade that allows cancer to colonize the body.
https://t.co/lYUyfRYOcP
Congratulations to @DanaFarber’s Alan D’Andrea, MD, and @judygarber5 on their election to the American Academy of Arts and Sciences.
➡️ https://t.co/EyNxFCTJKR
Now online: Spatial integration of protein and chromosomal states reveals early copy number changes and genotype-associated immune neighborhoods in serous ovarian cancer evolution https://t.co/WfF2BlcQTz
Our BCCB group is at #AACR26!
Led by Diana Garcia, and working with @DrDAbravanel
and I, we present the multi-omics and evolutionary analysis of the MBCproject
Session: PO.MCB08.05
When: Wed April 22 2026, 9 AM - 12 PM
Poster 7265
https://t.co/zC33AzNZFN
@DFCI_BreastOnc
Join us On April 11! Dr. Faina Nakhlis will talk about what happens in the OR, including Axillary Lymph Node Dissection, Modified Radical Mastectomy and Delayed Reconstruction as Standards of Care for IBC. Register Here: https://t.co/cQcqOfd2LF
PATINA study in @nejm
Establishes 'maintenance' therapy as the standard after induction for 1st line HER2+ MBC.
Congrats to @Otto_DFCI@DFCI_BreastOnc for remarkable persistence and work. https://t.co/s0IwF8MFdl
Genome editing for treatment of diseases has been constrained to blood, liver and eye targets due to delivery obstacles. But that's about to change.
a @NatureBiotech review
https://t.co/NJHiMlHMVY
Hanging out at #GI26: @ASCO mtg mascots Liam the Llama & Marty the Merlion. Liam’s 1st mtg was #ASCOQLTY25 - he’s pretty impressed w/GI. Marty, official mascot of #ASCOBT26, is gearing up for Breakthrough in Singapore. A merlion -1/2 lion, 1/2 fish- is Singapore’s mythical mascot
Congratulations to @AminNassarMD, named a recipient of an Emerging-Generation Award by @the_asci. E-Gen Awards recognize post-MD, pre–faculty appointment physician-scientists who are meaningfully engaged in immersive research.
@SmilowCancer@YaleHemOnc
Congratulations to Zachary A. Yochum, MD, PhD, recipient of the 2025 AACR-@ExelixisInc Renal Cell Carcinoma Research Fellowship. We look forward to his findings on ERV-specific T cells and their role in anti-tumor immunity and ICI response in renal cell carcinoma.